Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Long terme And NotWinfried Ilg

List of bibliographic references

Number of relevant bibliographic references: 93.
Ident.Authors (with country if any)Title
000140 Maria C. Rodriguez-Oroz [Espagne] ; Elena Moro [Canada] ; Paul Krack [France]Long-Term Outcomes of Surgical Therapies for Parkinson's Disease
000213 Bernard Ravina [États-Unis] ; Kenneth Marek [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Roger Kurlan [États-Unis] ; Alberto Ascherio [États-Unis] ; Flint Beal [États-Unis] ; James Beck [États-Unis] ; Emily Flagg [États-Unis] ; Wendy R. Galpern [États-Unis] ; Jennifer Harman [États-Unis] ; Anthony E. Lang [Canada] ; Michael Schwarzschild [États-Unis] ; Caroline Tanner [États-Unis] ; Ira Shoulson [États-Unis]Dopamine Transporter Imaging Is Associated With Long-Term Outcomes in Parkinson's Disease
000222 Jordan J. Elm [États-Unis]Design Innovations and Baseline Findings in a Long-Term Parkinson's Trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1
000532 Peggy Reiner [France] ; Damien Galanaud [France] ; Gaëlle Leroux [France] ; Marie Vidailhet [France] ; Julien Haroche [France] ; Du Le Thi Huong [France] ; Camille Frances [France] ; Thomas Papo [France] ; Christian De Gennes [France] ; Lucile Musset [France] ; Bertrand Wechsler [France] ; Zahir Amoura [France] ; Jean-Charles Piette [France] ; Nathalie Costedoat-Chalumeau [France]Long-Term Outcome of 32 Patients With Chorea and Systemic Lupus Erythematosus or Antiphospholipid Antibodies
000533 Elisa Garbayo [Espagne] ; Eduardo Ansorena [Espagne] ; Jose Luis Lanciego [Espagne] ; Maria Jose Blanco-Prieto [Espagne] ; Maria S. Aymerich [Espagne]Long-Term Neuroprotection and Neurorestoration by Glial Cell-Derived Neurotrophic Factor Microspheres for the Treatment of Parkinson's Disease
000534 Michele Tagliati [États-Unis] ; Paul Krack [France] ; Jens Volkmann [Allemagne] ; Tipu Aziz [Royaume-Uni] ; Joachim K. Krauss [Allemagne] ; Andreas Kupsch [Allemagne] ; Marie Vidailhet [France]Long-Term Management of DBS in Dystonia: Response to Stimulation, Adverse Events, Battery Changes, and Special Considerations
000535 Sudhansu Chokroverty [États-Unis]Long-Term Management Issues in Restless Legs Syndrome
000536 Codrin Lungu [États-Unis] ; Barbara I. Karp [États-Unis] ; Katharine Alter [États-Unis] ; Regina Zolbrod [États-Unis] ; Mark Hallett [États-Unis]Long-Term Follow-up of Botulinum Toxin Therapy for Focal Hand Dystonia: Outcome at 10 Years or More
000537 Mathias Toft [Norvège] ; Bard Lilleeng [Norvège] ; Jon Ramm-Pettersen [Norvège] ; Inger Marie Skogseid [Norvège] ; Vidar Gundersen [Norvège] ; Remo Gerdts [Norvège] ; Lena Pedersen [Norvège] ; Mona Skjelland [Norvège] ; Geir Ketil R Ste [Norvège] ; Espen Dietrichs [Norvège]Long-Term Efficacy and Mortality in Parkinson's Disease Patients Treated with Subthalamic Stimulation
000538 René Reese [Allemagne] ; Doreen Gruber [Allemagne] ; Thomas Schoenecker [Allemagne] ; Hansjörg Bazner [Allemagne] ; Christian Blahak [Allemagne] ; H. Holger Capelle [Allemagne] ; Daniela Falk [Allemagne] ; Jan Herzog [Allemagne] ; Marcus O. Pinsker [Allemagne] ; Gerd H. Schneider [Allemagne] ; Christoph Schrader [Allemagne] ; Gunther Deuschl [Allemagne] ; Hubertus M. Mehdorn [Allemagne] ; Andreas Kupsch [Allemagne] ; Jens Volkmann [Allemagne] ; Joachim K. Krauss [Allemagne]Long-Term Clinical Outcome in Meige Syndrome Treated with Internal Pallidum Deep Brain Stimulation
000551 Fabian Klostermann [Allemagne] ; Constanze Jugel [Allemagne] ; Frank Marzinzik [Allemagne]Jejunal Levodopa Infusion in Long-Term DBS Patients with Parkinson's Disease
000639 Ping-Lei Pan [République populaire de Chine] ; He-Han Tang [République populaire de Chine] ; QIN CHEN [République populaire de Chine] ; WEI SONG [République populaire de Chine] ; Hui-Fang Shang [République populaire de Chine]Desferrioxamine Treatment of Aceruloplasminemia: Long-term Follow-up
000696 Maurizio Zibetti [Italie] ; Aristide Merola [Italie] ; Laura Rizzi [Italie] ; Valeria Ricchi [Italie] ; Serena Angrisano [Italie] ; Corrado Azzaro [Italie] ; Carlo Alberto Artusi [Italie] ; Nichy Arduino [Italie] ; Alice Marchisio [Italie] ; Michele Lanotte [Italie] ; Mario Rizzone [Italie] ; Leonardo Lopiano [Italie]Beyond Nine Years of Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
000978 Asha Kishore [Inde] ; Ravimohan Rao [Inde] ; Syam Krishnan [Inde] ; Dilip Panikar [Inde] ; Gangadhara Sarma [Inde] ; MATHURANATH PAVAGADA SIVASANAKARAN [Inde] ; Sankara Sarma [Inde]Long-Term Stability of Effects of Subthalamic Stimulation in Parkinson's Disease: Indian Experience
000979 Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Pierre Pollak [France] ; Yves Agid [France] ; Stig Rehncrona [Suède] ; Jens Volkmann [Allemagne] ; Jaime Kulisevsky [Espagne] ; Jose A. Obeso [Espagne] ; Alberto Albanese [Italie] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Niall P. Quinn [Canada] ; Jans D. Speelman [Pays-Bas] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Alexandre Mendes [France] ; Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Annalena L. Tornqvist [Suède] ; Ron Ekberg [Suède] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Andres Gironell [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; Anna R. Bentivoglio [Italie] ; Maria F. Contarino [Italie, Pays-Bas] ; Luigi Romito [Italie] ; Massimo Scerrati [Italie] ; Marc Janssens [Pays-Bas] ; Anthony E. Lang [Canada]Long-Term Results of a Multicenter Study on Subthalamic and Pallidal Stimulation in Parkinson's Disease
000980 Laura Cif [France] ; Xavier Vasques [France] ; Victoria Gonzalez [France] ; Patrice Ravel [France] ; Brigitte Biolsi [France] ; Gwenaelle Collod-Beroud [France] ; Sylvie Tuffery-Giraud [France] ; Hassan Elfertit [France] ; Mireille Claustres [France] ; Philippe Coubes [France]Long-Term Follow-Up of DYT1 Dystonia Patients Treated by Deep Brain Stimulation: An Open-Label Study
000982 Galit Kleiner-Fisman [Canada] ; Andres Lozano [Canada] ; Elena Moro [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada]Long-Term Effect of Unilateral Pallidotomy on Levodopa-Induced Dyskinesia
000983 Arika Hasegawa [Japon] ; Takeshi Ikeuchi [Japon] ; Ryoko Koike [Japon] ; Nae Matsubara [Japon] ; Miyuki Tsuchiya [Japon] ; Hiroaki Nozaki [Japon] ; Atsushi Homma [Japon] ; Jiro Idezuka [Japon] ; Masatoyo Nishizawa [Japon] ; Osamu Onodera [Japon]Long-Term Disability and Prognosis in DentatorubralPallidoluysian Atrophy: a Correlation with CAG Repeat Length
000984 Daniel J. Dilorenzo [États-Unis] ; Joseph Jankovic [États-Unis] ; Richard K. Simpson [États-Unis] ; Hidehiro Takei [États-Unis] ; Suzanne Z. Powell [États-Unis]Long-Term Deep Brain Stimulation for Essential Tremor: 12-Year Clinicopathologic Follow-Up
000985 Elisabeth Wolf [Autriche] ; Klaus Seppi [Autriche] ; Regina Katzenschlager [Autriche] ; Guenter Hochschorner [Autriche] ; Gerhard Ransmayr [Autriche] ; Petra Schwingenschuh [Autriche] ; Erwin Ott [Autriche] ; Iris Kloiber [Autriche] ; Dietrich Haubenberger [Autriche] ; Eduard Auff [Autriche] ; Werner Poewe [Autriche]Long-Term Antidyskinetic Efficacy of Amantadine in Parkinson's Disease
000B23 C. Warren Olanow [États-Unis, Italie] ; Karl Kieburtz [États-Unis]Defining Disease-Modifying Therapies for PD- A Road Map for Moving Forward
000D20 Luigi M. Romito [Italie] ; Maria Fiorella Contarino [Italie] ; Nicola Vanacore [Italie] ; Anna Rita Bentivoglio [Italie] ; Massimo Scerrati [Italie] ; Alberto Albanese [Italie]Replacement of Dopaminergic Medication with Subthalamic Nucleus Stimulation in Parkinson's Disease : Long-Term Observation
000D38 Andrew Mckeon [États-Unis] ; J. Eric Ahlskog [États-Unis] ; James H. Bower [États-Unis] ; Keith A. Josephs [États-Unis] ; Joseph Y. Matsumoto [États-Unis]Psychogenic Tremor : Long Term Prognosis in Patients with Electrophysiologically-Confirmed Disease
000D68 Mariachiara Sensi [Italie] ; Michele A. Cavallo [Italie] ; Rocco Quatrale [Italie] ; Silvio Sarubbo [Italie] ; Sara Biguzzi [Italie] ; Cristian Lettieri [Italie] ; Jay G. Capone [Italie] ; Valeria Tugnoli [Italie] ; Maria Rosaria Tola [Italie] ; Roberto Eleopra [Italie]Pallidal Stimulation for Segmental Dystonia: Long Term Follow Up of 11 Consecutive Patients
000D98 A. Sebastian Schroeder [Allemagne] ; Birgit Ertl-Wagner [Allemagne] ; Stefanie Britsch [Allemagne] ; J. Michael Schroder [Allemagne] ; Stefan Nikolin [Allemagne] ; Joachim Weis [Allemagne] ; Wolfgang Müller-Felber [Allemagne] ; Inga Koerte [Allemagne] ; Maximilian Stehr [Allemagne] ; Steffen Berweck [Allemagne] ; Ingo Borggraefe [Allemagne] ; Florian Heinen [Allemagne]Muscle Biopsy Substantiates Long-Term MRI Alterations One Year After A Single Dose of Botulinum Toxin Injected into the Lateral Gastrocnemius Muscle of Healthy Volunteers
000E20 Robert A. Hauser [États-Unis] ; Mark F. Lew [États-Unis] ; Howard I. Hurtig [États-Unis] ; William G. Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; Cheryl J. Fitzer-Attas [Israël]Long-term Outcome of Early Versus Delayed Rasagiline Treatment in Early Parkinson's Disease
000E21 Jens Volkmann [Allemagne] ; Alberto Albanese [Italie] ; Jaime Kulisevsky [Espagne] ; Aana-Lena Tornqvist [Suède] ; Jean-Luc Houeto [France] ; Bernard Pidoux [France] ; Anne-Marie Bonnet [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Nadege Van Blercom [France] ; JING XIE [France] ; José Obeso [Espagne] ; Maria Cruz Rodriguez-Oroz [Espagne] ; Jurge Guridi [Espagne] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Alexandre A. Gironell [Espagne] ; Juan Molet [Espagne] ; Benta Pascual-Sedano [Espagne] ; Stig Rehncrona [Suède] ; Elena Moro [Canada] ; Anthony C. Lang [Canada] ; Andres M. Lozano [Canada] ; Anna Rita Bentivoglio [Italie] ; Massimo Scerrati [Italie] ; Maria Fiorella Contarino [Pays-Bas] ; Luigi Romito [Italie] ; Marc Janssens [Pays-Bas] ; Yves Agid [France]Long-Term Effects of Pallidal or Subthalamic Deep Brain Stimulation on Quality of Life in Parkinson's Disease
001193 David Maltete [France] ; Stéphane Derrey [France] ; Nathalie Chastan [France] ; Bertrand Debono [France] ; Emmanuel Gerardin [France] ; Pierre Freger [France] ; Bruno Mihout [France] ; Jean Francois Menard [France] ; Didier Hannequin [France]Microsubthalamotomy : An Immediate Predictor of Long-Term Subthalamic Stimulation Efficacy in Parkinson Disease
001204 Mitchell F. Brin [États-Unis] ; Cynthia L. Comella [États-Unis] ; Joseph Jankovic [États-Unis] ; Francis Lai [États-Unis] ; Markus Naumann [Allemagne]Long-Term Treatment with Botulinum Toxin Type A in Cervical Dystonia Has Low Immunogenicity by Mouse Protection Assay
001205 P. Richard Schuurman [Pays-Bas] ; D. Andries Bosch [Pays-Bas] ; Maruschka P. Merkus [Pays-Bas] ; Johannes D. Speelman [Pays-Bas]Long-Term Follow-Up of Thalamic Stimulation Versus Thalamotomy for Tremor Suppression
001206 Eugenia Mamikonyan [États-Unis] ; Andrew D. Siderowf [États-Unis] ; John E. Duda [États-Unis] ; Marc N. Potenza [États-Unis] ; Stacy Horn [États-Unis] ; Matthew B. Stem [États-Unis] ; Daniel Weintraub [États-Unis]Long-Term Follow-Up of Impulse Control Disorders in Parkinson's Disease
001273 Pedro J. Garcia Ruiz ; Angel Sesar Ignacio ; Begona Ares Pensado ; Alfonso Castro Garcia ; Fernando Alonso Frech ; Mercedes Alvarez Lopez ; José Arbelo Gonzalez ; Joan Baiges Octavio ; Juan Andrés Burguera Herandez ; Matilde Calopa Garriga ; Dulce Campos Blanco ; Belén Castano Garcia ; Manuel Carballo Cordero ; José Chacon Pena ; Anna Espino Ibanez ; Aranzazu Gorospe Onisalde ; Santiago Gimenez-Roldan ; Pilar Granes Ibanez ; Jorge Hernandez Vara ; Ramon Ibanez Alonso ; Félix Javier Jimenez Jimenez ; Jerzy Krupinski ; Jaime Kulisevsky Bojarsky ; Inés Legarda Ramirez ; Elena Lezcano Garcia ; Juan Carlos Martinez-Castrillo ; Dolores Mateo Gonzalez ; Francesc Miquel Rodriguez ; Pablo Mir Rivera ; Elena Munoz Fargas ; José Obeso Inchausti ; Jesus Olivares Romero ; José Olive Plana ; Pilar Otermin Vallejo ; Berta Pascual Sedano ; Victor Perez De Colosia Rama ; Isabel Perez Lopez-Fraile ; Albert Planas Cornes ; Victor Puente Periz ; Maria Cruz Rodriguez Oroz ; Dolores Sevillano Garcia ; Pilar Solis Perez ; José Suarez Munoz ; Julia Vaamonde Gamo ; Caridad Valero Merino ; Francesc Valldeoriola Serra ; José Miguel Velazquez Perez ; Rosa Yanez Bana ; Ivana Zamarbide CapdeponEfficacy of Long-Term Continuous Subcutaneous Apomorphine Infusion in Advanced Parkinson's Disease with Motor Fluctuations : A Multicenter Study
001279 Molly M. Sturman [États-Unis] ; David E. Vaillancourt [États-Unis] ; Mark B. Shapiro [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Roy A. E. Bakay [États-Unis] ; Daniel M. Corcos [États-Unis]Effect of Short and Long Term STN Stimulation Periods on Parkinsonian Signs
001368 Christopher G. Goetz [États-Unis] ; WENQING FAN [États-Unis] ; Sue Leurgans [États-Unis]Antipsychotic Medication Treatment for Mild Hallucinations in Parkinson's Disease : Positive Impact on Long-Term Worsening
001583 Alexandre Berney [Canada, Suisse] ; Michel Panisset [Canada] ; Abbas F. Sadikot [Canada] ; Alain Ptito [Canada] ; Alain Dagher [Canada] ; Maria Fraraccio [Canada] ; Ghislaine Savard [Canada] ; Marc Pell [Canada] ; Chawki Benkelfat [Canada]Mood Stability during Acute Stimulator Challenge in Parkinson's Disease Patients Under Long-Term Treatment with Subthalamic Deep Brain Stimulation
001609 Christopher Kenney [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis]Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders
001610 Selma Aybek [Suisse] ; Aline Gronchi-Perrin [Suisse] ; Alexandre Berney [Suisse] ; Sabina Catalano Chiuve [Suisse] ; Jean-Guy Villemure [Suisse] ; Pierre R. Burkhard [Suisse] ; Francois J. G. Vingerhoets [Suisse]Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease
001616 Panida Piboolnurak [Canada, Thaïlande] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; Janis M. Miyasaki [Canada] ; Jean A. Saint-Cyr [Canada] ; Yu-Yan W. Poon [Canada] ; William D. Hutchison [Canada] ; Jonathan O. Dostrovsky [Canada] ; Elena Moro [Canada]Levodopa response in long-term bilateral Subthalamic stimulation for Parkinson's disease
001778 Roberto Vetrugno [Italie] ; Chiara La Morgia [Italie] ; Roberto D'Angelo [Italie] ; Daniela Loi [Italie] ; Federica Provini [Italie] ; Giuseppe Plazzi [Italie] ; Pasquale Montagna [Italie]Augmentation of restless legs syndrome with long-term tramadol treatment
001908 Jacques Montplaisir [Canada] ; Jeff Karrasch [Australie] ; Jean Haan [Allemagne] ; Dieter Volc [Autriche]Ropinirole is effective in the long-term management of restless legs syndrome : A randomized controlled trial
001A03 Eus J. W. Van Someren [Pays-Bas] ; Myrthe D. Pticek [Pays-Bas] ; Johannes D. Speelman [Pays-Bas] ; Peter R. Schuurman [Pays-Bas] ; Rianne Esselink [Pays-Bas] ; Dick F. Swaab [Pays-Bas]New actigraph for long-term tremor recording
001A26 Emmanuel Roze [France] ; Marie Vidailhet [France] ; Nenad Blau [Suisse] ; Lisbeth Birk Moller [Danemark] ; Diane Doummar [France] ; Thierry Billette De Villemeur [France] ; Anne Roubergue [France]Long-term follow-up and adult outcome of 6-pymvoyl-tetrahydropterin synthase deficiency
001A27 Andrew Siderowf [États-Unis] ; Jurg L. Jaggi [États-Unis] ; Sharon X. Xie [États-Unis] ; Catherine Loveland-Jones [États-Unis] ; Lewis Leng [États-Unis] ; Howard Hurtig [États-Unis] ; Amy Colcher [États-Unis] ; Matthew Stern [États-Unis] ; Kelvin L. Chou [États-Unis] ; Grace Liang [États-Unis] ; Heather Maccarone [États-Unis] ; Tanya Simuni [États-Unis] ; Gordon Baltuch [États-Unis]Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced parkinson's disease
001A28 Werner Poewe [Autriche] ; Erik Wolters [Pays-Bas] ; Murat Emre [Turquie] ; Marco Onofrj [Italie] ; Chuanchieh Hsu [États-Unis] ; Sibel Tekin [États-Unis] ; Roger Lane [États-Unis]Long-term benefits of rivastigmine in dementia associated with parkinson's disease : An active treatment extension study
001A29 Martin Krause [Allemagne] ; Wolfgang Fogel [Allemagne] ; Volker Tronnier [Allemagne] ; Sabine Pohle [Allemagne] ; Konstanze Hörtnagel [Allemagne] ; Ute Thyen [Allemagne] ; Jens Volkmann [Allemagne]Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration
001E02 Brian Berman [États-Unis] ; Lauren Seeberger [États-Unis] ; Rajeev Kumar [États-Unis]Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia
001E03 J. Carsten Möller [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Jürgen Koster [Allemagne] ; Gianni Pezzoli [Italie] ; Leandro Provinciali [Italie]Long-term efficacy and safety of pramipexole in advanced Parkinson's disease : Results from a European multicenter trial
001E04 Inger Marie Skogseid [Norvège] ; Jo R Islien [Norvège] ; Bj Rgulf Claussen [Norvège] ; Emilia Kerty [Norvège]Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia
001E05 Nicte I. Mejia [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Joseph Jankovic [États-Unis]Long-term botulinum toxin efficacy, safety, and immunogenicity
001E47 Hans-Christian Jabusch [Allemagne] ; Dorothea Zschucke [Allemagne] ; Alexander Schmidt [Allemagne] ; Stephan Schuele [États-Unis] ; Eckart Altenmüller [Allemagne]Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients
002387 Claudia Trenkwalder [Allemagne] ; Victor Collado Seidel [Allemagne] ; Jörg Kazenwadel [Suisse] ; Thomas C. Wetter [Allemagne] ; Wolfgang Oertel [Allemagne] ; Roland Selzer [Allemagne] ; Ralf Kohnen [Allemagne]One-year treatment with standard and sustained-release levodopa: Appropriate long-term treatment of restless legs syndrome?
002414 Hubert H. Fernandez [États-Unis] ; Martha E. Trieschmann [États-Unis] ; Monica A. Burke [États-Unis] ; Carol Jacques [États-Unis] ; Joseph H. Friedman [États-Unis]Long-term outcome of quetiapine use for psychosis among parkinsonian patients
002415 Stig Rehncrona [Suède] ; Bo Johnels [Suède] ; Hakan Widner [Suède] ; Anna-Lena Törnqvist [Suède] ; Marwan Hariz [Suède] ; Olof Sydow [Suède]Long-term efficacy of Thalamic deep brain stimulation for tremor: Double-blind assessments
002421 Wolfgang N. Löscher [Autriche] ; Eugen Trinka [Autriche]Late delayed postradiation spinal myoclonus or psychogenic movement disorder?
002701 Franck Durif [France] ; Jean-Jacques Lemaire [France] ; Bérengère Debilly [France] ; Gérard Dordain [France]Long-term follow-up of globus pallidus chronic stimulation in advanced Parkinson's Disease
002702 G-Y. R. Hsiung [Canada] ; S. K. Das [Canada] ; R. Ranawaya [Canada] ; A.-L. Lafontaine [Canada] ; O. Suchowersky [Canada]Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period
002826 Azi H. Rajput [Canada] ; Mark E. Fenton [Canada] ; Sam Birdi [Canada] ; Rob Macaulay [Canada] ; David George [Canada] ; Bohdar Rozdilsky [Canada] ; Lee C. Ang [Canada] ; Ambikaipakan Senthilselvan [Canada] ; Oleh Hornykiewicz [Autriche]Clinical-pathological study of levodopa complications
002847 Francesc Valldeoriola [Espagne] ; Manuela Pilleri [Espagne] ; Eduardo Tolosa [Espagne] ; José L. Molinuevo [Espagne] ; Jordi Rumia [Espagne] ; Enric Ferrer [Espagne]Bilateral subthalamic stimulation monotherapy in advanced Parkinson's disease: Long-term follow-up of patients
002867 Marcelo Merello [Argentine] ; Maria I. Nouzeilles [Argentine] ; Gabriel Piran Arce [Argentine] ; Ramon Leiguarda [Argentine]Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis
002963 William C. Koller [États-Unis] ; Kelly E. Lyons [États-Unis] ; Steven B. Wilkinson [États-Unis] ; Alexander I. Troster [États-Unis] ; Rajesh Pahwa [États-Unis]Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor
002964 Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France]Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease
002965 Arthur S. Walters [États-Unis] ; Juliane Winkelmann [Allemagne] ; Claudia Trenkwalder [Allemagne] ; June M. Fry [États-Unis] ; Vandana Kataria [États-Unis] ; Mary Wagner [États-Unis] ; Rakesh Sharma [États-Unis] ; Wayne Hening [États-Unis] ; LIREN LI [États-Unis]Long-term follow-up on restless legs syndrome patients treated with opioids
002A18 Orhan Barlas [Turquie] ; Hasmet A. Hanagasi [Turquie] ; Murat Imer [Turquie] ; Hüseyin A. Sahin [Turquie] ; Serra Sencer [Turquie] ; Murat Emre [Turquie]Do unilateral ablative lesions of the subthalamic nucleu in parkinsonian patients lead to hemiballism?
002A36 Krishna P. Datla [Royaume-Uni] ; Stavia B. Blunt [Royaume-Uni] ; David T. Dexter [Royaume-Uni]Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl3 nigrostriatal lesions
002A89 M. S. Baron [États-Unis] ; J. L. Vitek [États-Unis] ; R. A. E. Bakay [États-Unis] ; J. Green [États-Unis] ; W. M. Mcdonald [États-Unis] ; S. A. Cole [États-Unis] ; M. R. Delong [États-Unis]Treatment of advanced Parkinson's Disease by unilateral posterior GPi pallidotomy : 4-Year results of a pilot study
002B28 Stacey K. Jankelowitz [Australie] ; Paul D. Clouston [Australie]Radiation-induced 'meige syndrome'
002B47 A. Brashear [États-Unis] ; K. Bergan [États-Unis] ; J. Wojcieszek [États-Unis] ; E. R. Siemers [États-Unis] ; W. Ambrosius [États-Unis]Patients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A
002C96 P. Kanovsky [République tchèque] ; H. Streitova [République tchèque] ; M. Bares [République tchèque] ; H. Hortova [République tchèque]Treatment of facial and orolinguomandibular tardive dystonia by botulinum toxin A : Evidence of a long-lasting effect
002C98 S. A. Factor [États-Unis] ; E. S. Molho [États-Unis]Transient benefit of amantadine in Parkinson's disease : The facts about the myth
002D14 A. Lagueny [France] ; F. Tison [France] ; P. Burbaud [France] ; G. Le Masson [France] ; P. Kien [France]Stimulus-sensitive spinal segmental myoclonus improved with injections of botulinum toxin type A
002E73 R. Ceravolo [Italie] ; S. Salvetti [Italie] ; P. Piccini [Royaume-Uni] ; C. Lucetti [Italie] ; G. Gambaccini [Italie] ; U. Bonuccelli [Italie]Acute and chronic effects of clozapine in essential tremor
002F08 M. C. Rodriguez [Espagne] ; O. J. Guridi [Espagne] ; L. Alvarez [Cuba] ; K. Mewes [États-Unis] ; R. Macias [Cuba] ; J. Vitek [États-Unis] ; M. R. Delong [États-Unis] ; J. A. Obeso [Espagne]The subthalamic nucleus and tremor in Parkinson's disease
002F14 J. D. Speelman [Pays-Bas] ; P. R. Schuurman [Pays-Bas] ; R. M. A. De Bie [Pays-Bas] ; D. A. Bosch [Pays-Bas]Thalamic surgery and tremor
002F15 N. Syed [États-Unis] ; J. Murphy [États-Unis] ; T. Jr Zimmerman [États-Unis] ; M. H. Mark [États-Unis] ; J. I. Sage [États-Unis]Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease
002F80 S. Spieker [Allemagne] ; A. Boose [Allemagne] ; S. Breit [Allemagne] ; J. Dichgans [Allemagne]Long-term measurement of tremor
002F81 Alim-Louis Benabid [France] ; A. Benazzouz [France] ; D. Hoffmann [France] ; P. Limousin [France] ; P. Krack [France] ; Pierre Pollak [France]Long-term electrical inhibition of deep brain targets in movement disorders
003004 R. B. Banati [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; S. B. Blunt [Royaume-Uni]Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease
003110 S. Spieker [Allemagne] ; V. Ströle [Allemagne] ; A. Sailer [Allemagne] ; A. Boose [Allemagne] ; J. Dichgans [Allemagne]Validity of long-term electromyography in the quantification of tremor
003127 J. P. Larsen [Norvège] ; J. Boas [Danemark]The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability : An interim analysis of a Norwegian-Danish 5-year study
003131 K. J. Werhahn [Royaume-Uni] ; P. Brown [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]The clinical features and prognosis of chronic posthypoxic myoclonus
003202 W. H. Jost [Allemagne] ; K. Schimrigk [Allemagne]Long-term results with cisapride in Parkinson's disease
003203 A. Antonini [Suisse] ; J. Schwarz [Suisse] ; W. H. Oertel [Suisse] ; O. Pogarell [Suisse] ; K. L. Leenders [Suisse, Allemagne]Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease : A study with positron emission tomography and [11C]raclopride
003291 A. Negrotti [Italie] ; S. Calzetti [Italie]A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism
003394 M. A. Nance [États-Unis] ; G. Sanders [États-Unis]Characteristics of individuals with Huntington disease long-term care
003479 J. Kulisevsky [Espagne] ; M. L. Berthier ; A. AvilaLongitudinal evolution of prefrontral leucotomy in Tourette's syndrome
003480 R. Inzelberg [Israël] ; P. Nisipeanu ; M. J. Rabey ; A. D. KorczynLong-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease
003570 J. P. Jr Bennett [États-Unis] ; E. R. Landow ; S. Dietrich ; L. A. SchuhSuppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction
003791 P. Montagna [Italie] ; A. S. Gabellini ; L. Monari ; E. LugaresiParkinsonian syndrome after long-term treatment with clebopride
003932 M. Shandling ; P. L. Carlen ; A. E. LangParkinsonism in alcohol withdrawal: a follow-up study
003943 S. Boyce ; C. E. Clarke ; R. Luquin ; D. Peggs ; R. G. Robertson ; I. J. Mitchell ; M. A. Sambrook ; A. R. CrossmanInduction of chorea and dystonia in parkinsonian primates
003A32 S. K. Singh ; Joseph Jankovic [États-Unis]Tardive dystonia in patients with Tourette's syndrome
003A43 G. Pezzoli ; S. Tesei ; C. Ferrante ; E. Cossutta ; A. Zecchinelli ; G. ScarlatoMadopar HBS in fluctuating Parkinsonian patients: two-year treatment
003A50 M. Hietanen ; H. TeravainenDementia and treatment with L-dopa in Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024